Use of Continuous Glucose Monitors in Publicly-Insured Youth With Type 2 Diabetes - A Pilot and Feasibility Study

Inclusion Criteria

• •public insurance
• •between ages 4-19.99 years inclusive
• •diagnosis of T2D (diabetes autoantibody negative) followed in the Pediatric Endocrinology clinic at Stanford Children's Health
• •HbA1C greater than 6.5% at enrollment
• •interested in starting on a continuous glucose monitor
• •have access to a mobile device that is compatible with CGM applications or willing to use CGM receiver provided